Finance

Lists
000963:SHE
Huadong Medicine Co., Ltd.
CNÂ¥26.26
-1.35%
(-0.36) 1D
Sep 11, 3:04:57 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000963...
Open
CNÂ¥26.59
High
CNÂ¥26.59
Low
CNÂ¥26.07
Mkt. cap
46.68B
Avg. vol.
24.40M
Volume
10.20M
P/E ratio
13.28
52-wk high
CNÂ¥43.78
52-wk low
CNÂ¥25.63
EPS
CNÂ¥1.98
Shares outstanding
1.75B
No. of employees
19K
Open
CNÂ¥26.59
High
CNÂ¥26.59
Low
CNÂ¥26.07
Mkt. cap
46.68B
Avg. vol.
24.40M
Volume
10.20M
P/E ratio
13.28
52-wk high
CNÂ¥43.78
52-wk low
CNÂ¥25.63
EPS
CNÂ¥1.98
Shares outstanding
1.75B
No. of employees
19K
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19.1K
FoundedMar 31, 1993
Headquarters-
SectorHealth care provider
Websiteeastchinapharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
10.99B
10.95B
11.18B
10.88B
Cost of goods sold
7.39B
7.79B
7.39B
7.45B
Cost of revenue
7.39B
7.79B
7.39B
7.45B
Research and development expenses
507.92M
245.56M
350.37M
396.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93B
1.99B
2.19B
1.92B
Operating expense
2.33B
2.51B
2.60B
2.41B
Total operating expenses
9.72B
10.31B
9.99B
9.86B
Operating income
1.27B
642.86M
1.19B
1.03B
Other non operating income
-72.11M
53.61M
-4.09M
-10.61M
EBT including unusual items
1.07B
753.84M
1.19B
1.02B
EBT excluding unusual items
1.19B
723.38M
1.19B
1.01B
Income tax expense
130.93M
84.85M
195.03M
176.07M
Effective tax rate
12.24%
11.26%
16.36%
17.28%
Other operating expenses
-105.72M
224.00M
58.88M
63.39M
Net income
933.09M
666.42M
1.00B
858.57M
Net profit margin
8.49%
6.09%
8.96%
7.89%
Earnings per share
0.54
-
-
-
Interest and investment income
26.71M
12.97M
20.16M
18.36M
Interest expense
-33.70M
-
-19.18M
-12.03M
Net interest expenses
-6.99M
12.97M
979.40K
6.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.46B
873.59M
1.43B
1.29B
Gain or loss from assets sale
-6.20M
-2.26M
-
-1.42M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps